Advanced Medical Solutions taps Liz Shanahan for chair

Advanced Medical Solutions

Tissue-healing technology developer Advanced Medical Solutions has tapped Liz Shanahan to take over as chair from Peter Allen.

Source: Sharecast

Shanahan, a current non-executive director of the group, will succeed Allen on 1 January 2024, following a handover period. Allen had previously signalled his intention to step down after 10 years with the group.

The AIM-listed group noted that Shanahan was a life sciences entrepreneur with extensive experience advising leading global pharmaceutical and healthcare organisations on their communications.

She currently serves as a non-executive director of Inspiration Healthcare and Celadon Pharmaceuticals and was previously a non-executive director at UDG Healthcare until its £2.8bn takeover in August 2021.

Chief executive Chris Meredith said: "We look forward to welcoming Liz as Chair in January. Her many years of life sciences experience and significant contribution to AMS since joining as a non-executive director made her the ideal candidate to now lead the board from 2024 onwards. Having worked with Liz for the past years, I know the benefit, insight and strategic guidance Liz will bring as we work closely together to execute the AMS growth strategy."

As of 1000 BST, AMS shares were up 1.49% at 204.0p.

Reporting by Iain Gilbert at Sharecast.com

Exchange: London Stock Exchange
Sell:
192.40 p
Buy:
194.80 p
Change:
-1.20
(-0.62%)
Date:
Prices delayed by at least 15 minutes

Compare our accounts

Whether you're looking for a Share Dealing Account, Stocks and Shares ISA or a Self-Invested Personal Pension (SIPP), we've got an account to suit your needs.

IWeb is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.